The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...
The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035[1], driven by a ...
Study Finds on MSN
Viral Protein Found In Cancer, Lupus, ALS Traced To Infection From Millions Of Years Ago
Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...
News-Medical.Net on MSN
Minimal residual disease monitoring can transform breast cancer care
Despite major therapeutic advances, breast cancer remains prone to recurrence, particularly in patients with early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback